SAN FRANCISCO—September 15, 2025—SPRY Therapeutics Inc. today announced the launch of the SPRY Prior Authorization & Eligibility Solution, the first AI-powered solution purpose-built for rehab therapy clinics. The solution automates up to 80% of prior authorization workflows while ensuring all authorizations are completed through a combination of AI automation and expert review. It reduces related denials by up to 75% and provides real-time, unlimited eligibility verification while streamlining processes across major payers, including Carelon/BCBS, UnitedHealthcare, and Humana.
SPRY's solution arrives at a critical juncture as rehab therapy clinics prepare for CMS’s 2026 electronic prior authorization mandate. The platform's FHIR-compatible APIs support integration with evolving electronic authorization requirements. AI agents manage the end-to-end authorization workflow, from reading clinical documentation to submitting requests and securing approvals, while processing authorizations up to a week before scheduled appointments. This advance timeline gives clinics the opportunity to resolve discrepancies before patients arrive. Real-time checks support walk-ins and help reduce last-minute cancellations.
AI Agents Execute Complete Authorization Workflow
SPRY’s custom AI agents manage the end-to-end authorization workflow, from determination through approval, reducing manual intervention for most cases while proactively identifying expiring authorizations and initiating renewals before they affect patient care. The platform incorporates integrated verification protocols with automated audit trails to ensure accuracy prior to submission. The automation adapts to handle complex authorization scenarios and payer website changes automatically. To maximize accuracy, SPRY uses a human-in-the-loop quality assurance layer, ensuring all cases are validated before submission, so clinics benefit from both automation speed and expert oversight.
The system runs eligibility checks automatically at scheduling, with built-in verification that flags suspicious values for quick review. SPRY’s therapy-specific rules engine understands requirements such as visit caps and modality limitations, with nightly re-verification performed for plans subject to mid-month changes.The platform works seamlessly within SPRY’s EMR or as a standalone service connected to third-party EMRs, enabling clinics to manage authorizations and eligibility from a single dashboard without portal-hopping.erapist documentation, completes payer medical questionnaires, and secures authorizations up to a week before patients arrive. These clinics haven’t had authorization-related appointment cancellations in months. The future isn’t about tracking authorizations, it’s about AI that executes the work so therapists can stay focused on what they do best: treating patients.”
Early Adopters Report Significant Operational Improvements
Renew Physiotherapy achieved denial rates of just 0.57% over two months of live operation while automating 75% of its authorization workflow.
Platform performance metrics validate these results:
The SPRY Prior Authorization & Eligibility Solution is now available nationwide. Registration details for the September 17 webinar are available on the SPRY.
About SPRY
SPRY Therapeutics Inc. is an AI-native platform built exclusively for outpatient rehab, trusted by leading clinics and networks including CAM Physical Therapy, The Therapy Network, WestArm Physical Therapy, Excel Therapy, and OC Sports & Rehab. Purpose-built for physical, occupational, and speech therapy, SPRY unifies digital intake, real-time eligibility verification, AI-assisted documentation, coding, billing, payments, and analytics into one seamless workflow—helping clinics cut administrative work by up to 80% and achieve clean-claim rates consistently above 95%. With top ratings on G2 (4.8/5) and Capterra (4.9/5) for usability, configurability, and responsive support, SPRY is setting a new standard for rehab practices that want to grow revenue while keeping clinicians focused on patient care. For more information, visit www.sprypt.com and follow us on LinkedIn.
Press Contact:
Chiya Ahuja
SPRY Therapeutics Inc.
chiyaa@spryhealth.care
+91-790-512-8640